Carter Charles Ross
Transaction: 07/06/2026
OTHER
Change
+206,250
Price
$1.65
Filing
07/08/2026
Type
OTHER
Ovid Therapeutics Inc.
OVID • Biotechnology
$2.80
▲ +0.02 (+0.72%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$522.59M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.1Healthy liquidity · 10.91Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:12 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.80
Change0.72%
Market Cap$522.59M
52W Range0.81 - 3.10
Beta0.23
Gross Margin95.86%
Oper. Margin-5.85%
Profit Margin-2.40%
Debt/Eq0.10
Current Ratio10.91
Quick Ratio10.91
Target$5.50
Price$2.80
Change0.72%
Market Cap$522.59M
52W Range0.81 - 3.10
Beta0.23
Gross Margin95.86%
Oper. Margin-5.85%
Profit Margin-2.40%
Debt/Eq0.10
Current Ratio10.91
Quick Ratio10.91
Target$5.50
Target Upside96.43%
Target Median$5.50
Target Range4.00 - 7.00
Volume2.24M
Avg Volume2.48M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0.1Healthy liquidity · 10.91Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$4.00
Mean
$5.50
Median
$5.50
High
$7.00
Insider Transactions
Recent executive and insider activity
Carter Charles Ross
Transaction: 07/06/2026
OTHER
Change
0
Price
Not reported
Filing
07/08/2026
Type
OTHER
Greka Anna
Transaction: 06/15/2026
OTHER
Change
0
Price
Not reported
Filing
06/17/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Carter Charles Ross | OTHER | +206,250 | $1.65 | 07/06/2026 | 07/08/2026 |
| Carter Charles Ross | OTHER | 0 | Not reported | 07/06/2026 | 07/08/2026 |
| Greka Anna | OTHER | 0 | Not reported | 06/15/2026 | 06/17/2026 |
| Greka Anna | BUY | +130,000 | $2.26 | 06/15/2026 | 06/17/2026 |
| Fitzgerald Kevin Joseph | BUY | +17,578 | $2.56 | 04/07/2026 | 04/09/2026 |
| Friedman Bart | BUY | +8,789 | $2.56 | 04/07/2026 | 04/09/2026 |
| PAPADOPOULOS STELIOS | BUY | +17,578 | $2.56 | 04/07/2026 | 04/09/2026 |
| LEVIN JEREMY M | SELL | -47,333 | $1.40 | 03/23/2026 | 03/25/2026 |
| LEVIN JEREMY M | BUY | +47,333 | $1.40 | 03/23/2026 | 03/25/2026 |
| Rona Jeffrey A | BUY | +68,125 | Not reported | 02/26/2026 | 03/02/2026 |
| Rona Jeffrey A | BUY | +408,750 | $1.65 | 02/26/2026 | 03/02/2026 |
| Bernstein Karen | BUY | +65,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| DUNCAN BARBARA GAYLE | BUY | +65,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| Friedman Bart | BUY | +65,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| Fitzgerald Kevin Joseph | BUY | +65,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| LEVIN JEREMY M | BUY | +957,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| PAPADOPOULOS STELIOS | BUY | +65,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| ALEXANDER MARGARET A. | BUY | +1,435,000 | $1.65 | 02/26/2026 | 03/02/2026 |
| Rona Jeffrey A | SELL | -8,541 | $1.45 | 02/23/2026 | 03/02/2026 |
| ALEXANDER MARGARET A. | SELL | -11,656 | $1.45 | 02/23/2026 | 03/02/2026 |